{
    "Trade/Device Name(s)": [
        "i-STAT CG8+ cartridge with the i-STAT 1 System"
    ],
    "Submitter Information": "Abbott Point of Care, Inc.",
    "510(k) Number": "K230300",
    "Predicate Device Reference 510(k) Number(s)": [
        "K191360"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFP",
        "JPI"
    ],
    "Summary Letter Date": "October 27, 2023",
    "Summary Letter Received Date": "September 29, 2023",
    "Submission Date": "September 28, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.1145",
        "21 CFR 864.6400"
    ],
    "Regulation Name(s)": [
        "Calcium Test System",
        "Device, Hematocrit, Measuring"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "hematology",
        "POCT"
    ],
    "Analyte(s)": [
        "Ionized calcium",
        "Hematocrit"
    ],
    "Specimen Type(s)": [
        "Arterial whole blood",
        "Venous whole blood",
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Balanced heparin tube",
        "Lithium heparin tube",
        "Capillary tube (with balanced heparin)"
    ],
    "Instrument(s)/Platform(s)": [
        "i-STAT 1 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-selective electrode potentiometry",
        "Conductometric method"
    ],
    "Methodologies": [
        "Electrochemical quantification",
        "Conductometry"
    ],
    "Submission Type(s)": [
        "Cartridge",
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for i-STAT CG8+ cartridge with the i-STAT 1 System for quantification of ionized calcium and hematocrit in whole blood at the point of care or clinical laboratory.",
    "Indications for Use Summary": "In vitro quantification of ionized calcium and hematocrit in arterial, venous, or capillary whole blood in point of care or clinical laboratory settings to aid in diagnosis, monitoring, and treatment of related conditions.",
    "fda_folder": "Clinical Chemistry"
}